**Core Concept**
The development of cataract in diabetes is a complex process involving the accumulation of sorbitol within the lens of the eye, leading to osmotic changes and eventual opacification. This process is closely linked to the enzyme aldose reductase, which plays a key role in the polyol pathway.

**Why the Correct Answer is Right**
The correct answer is related to the polyol pathway, where glucose is reduced to sorbitol by the enzyme aldose reductase. In diabetes, high glucose levels lead to increased activity of this enzyme, resulting in the accumulation of sorbitol within the lens. This accumulation causes water to enter the lens, leading to osmotic changes and eventually the development of cataracts. Aldose reductase inhibitors have been explored as a potential treatment for diabetic cataracts.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not directly relate to the development of cataracts in diabetes. While oxidative stress may contribute to the development of cataracts, it is not the primary mechanism in diabetes.
**Option B:** This option is incorrect as it is not directly related to the development of cataracts in diabetes. While inflammation may play a role in the development of cataracts, it is not the primary mechanism in diabetes.
**Option C:** This option is incorrect as it is not directly related to the development of cataracts in diabetes. While advanced glycosylation end-products (AGEs) may contribute to the development of cataracts, they are not the primary mechanism in diabetes.

**Clinical Pearl / High-Yield Fact**
Aldose reductase inhibitors have been explored as a potential treatment for diabetic cataracts, highlighting the importance of this enzyme in the development of cataracts in diabetes.

**Correct Answer:** A. Aldose reductase